Waters Corporation Interest Expense 2011-2026 | WAT

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Waters Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
14.3 M	19 M	98.9 M	48.8 M	44.9 M	49.1 M	48.7 M	48.6 M	56.8 M	44.9 M	36.2 M	34.2 M	30 M	28.1 M	22 M	13.9 M	11 M	38.5 M	-56.5 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
98.9 M	-56.5 M	33.2 M

Quarterly Interest Expense Waters Corporation

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2	2010-Q1	2009-Q3	2009-Q2
48 M	26.6 M	14.4 M	14.3 M	-	21.4 M	23.7 M	25.5 M	-	30.4 M	23.3 M	14.4 M	-	12.4 M	-	11.1 M	10.9 M	11.1 M	12 M	10.9 M	11.1 M	10.9 M	13 M	14.1 M	14.2 M	11.5 M	11.4 M	11.6 M	11.7 M	11.4 M	11.7 M	13.8 M	15.3 M	14.8 M	14.1 M	12.7 M	12.1 M	11.7 M	11 M	10.1 M	9.2 M	9.02 M	9.05 M	8.98 M	9.67 M	9.06 M	7.97 M	7.49 M	7.93 M	7.36 M	7.58 M	7.18 M	7.6 M	7.11 M	6.88 M	6.49 M	6.68 M	6.16 M	5.05 M	4.08 M	3.81 M	3.62 M	-2.61 M	-2.86 M	-2.65 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
48 M	-2.86 M	11.6 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Co-Diagnostics CODX	106 K	$ 1.29	-20.86 %	$ 1.72 M	USA
Agilent Technologies A	81 M	$ 111.67	-1.39 %	$ 33.9 B	USA
Castle Biosciences CSTL	144 K	$ 19.22	1.8 %	$ 557 M	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Fulgent Genetics FLGT	561 K	$ 15.84	-2.16 %	$ 479 M	USA
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	235 K	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Illumina ILMN	-292 M	$ 141.26	-1.38 %	$ 22.5 B	USA
Interpace Biosciences IDXG	-394 K	$ 1.8	-	$ 7.96 M	USA
CareDx, Inc CDNA	524 K	$ 19.81	-3.34 %	$ 1.06 B	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	31.3 M	$ 93.52	-3.26 %	$ 6.31 B	USA
Medpace Holdings MEDP	-5.34 M	$ 417.74	-0.34 %	$ 12.1 B	USA
Mettler-Toledo International MTD	68.5 M	$ 1 039.9	-0.19 %	$ 21.4 B	Schweiz
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Myriad Genetics MYGN	800 K	$ 3.61	-0.41 %	$ 334 M	USA
Genetic Technologies Limited GENE	15.2 K	-	-	$ 7.1 B	Australia
NeoGenomics NEO	296 K	$ 8.28	-0.96 %	$ 1.06 B	USA
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	-95 K	$ 18.7	-1.22 %	$ 419 M	USA
Natera NTRA	9.32 M	$ 188.14	-4.45 %	$ 18.5 B	USA
Charles River Laboratories International CRL	-22.6 M	$ 154.29	-3.04 %	$ 7.65 B	USA
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
Koninklijke Philips N.V. PHG	288 M	$ 25.27	-0.9 %	$ 24 B	Niderland
Guardant Health GH	-10.5 M	$ 94.56	-4.16 %	$ 11.9 B	USA
Personalis PSNL	205 K	$ 6.45	-3.95 %	$ 576 M	USA
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
ICON Public Limited Company ICLR	337 M	$ 117.67	0.5 %	$ 9.71 B	Irlanda
Senseonics Holdings SENS	-23 K	$ 5.7	-2.06 %	$ 238 M	USA
Soleno Therapeutics SLNO	2.58 M	$ 52.99	-	$ 2.69 B	USA
QIAGEN N.V. QGEN	-6.65 M	-	-	$ 10.6 B	Niderland
Biomerica BMRA	367	$ 2.36	-2.07 %	$ 5.42 M	USA
Laboratory Corporation of America Holdings LH	224 M	$ 251.95	-0.81 %	$ 21 B	USA
Thermo Fisher Scientific TMO	-12 M	$ 439.75	-1.87 %	$ 166 B	USA
Trinity Biotech plc TRIB	6.75 M	$ 0.57	-1.7 %	$ 205 M	Irlanda
Celcuity CELC	5.33 M	$ 134.2	-0.39 %	$ 6.27 B	USA
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Twist Bioscience Corporation TWST	-903 K	$ 48.67	-8.08 %	$ 2.91 B	USA
Neogen Corporation NEOG	38.1 M	$ 8.22	-2.49 %	$ 1.78 B	USA
Quest Diagnostics Incorporated DGX	26 M	$ 187.17	-0.41 %	$ 20.8 B	USA
Invitae Corporation NVTA	56.7 M	-	-	$ 21.2 M	USA